Catalog Number : 2599693
Favipiravir is a potent and selective inhibitor of RNA-dependent RNA polymerase of RNA viruses. It is reported to be effective against a wide range of types and subtypes of viruses. Favipiravir is metabolized into its active form of favipiravir-ribofuranosyl-5'-triphosphate (favipiravir-RTP). It is currently being researched as a potential treatment for COVID-19
T 705, T-705, Favilavir, Avigan
Product should be kept at -20°C.
Furuta, Y., Gowen, B. B., Takahashi, K., Shiraki, K., Smee, D. F., & Barnard, D. L. (2013). Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral research, 100(2), 446-454. Rocha-Pereira, J., Jochmans, D., Dallmeier, K., Leyssen, P., Nascimento, M. S. J., & Neyts, J. (2012). Favipiravir (T-705) inhibits in vitro norovirus replication. Biochemical and biophysical research communications, 424(4), 777-780. Chen, C., Huang, J., Cheng, Z., Wu, J., Chen, S., Zhang, Y., ... & Yin, P. (2020). Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial. medRxiv.